ArticleFrontiers in genetics2026
MoJKNet: a jumping knowledge graph framework for multi-omics cancer subtype prediction.
Article in Frontiers in genetics, 2026. The graph could read no effect estimate from its abstract, so it casts no vote on the map. Not yet cited in PubMed.
What it found
Each row is one number read from the abstract, on the scale the paper reported it, with its interval. Left of the dashed line favours the treatment, right favours the comparator. Under each row is the sentence it came from. New to these charts? A ten-minute tutorial.
The abstract states no effect estimate the extractor could read, or names no intervention and outcome on the map, so this paper lights no cell and moves no belief. It is still indexed, cited and linked below.
The trial behind it
Trials whose registry record cites this paper, or whose number appears in the abstract. A trial that started after this paper was published is citing it as background, not reporting it.
Neither the registry nor the abstract names a trial number. If this is a trial report, that itself is worth knowing.
Who cites it
0 citing papers in PubMed.
No citing paper in PubMed yet.
Corrections and comments
PubMed lists nothing against this paper. Absence here is not a guarantee, only a check that was made.
Authors and funding
3 authors.
Funding
No grant is acknowledged in the PubMed record.
Abstract
Cancer remains one of the leading causes of morbidity and mortality worldwide and poses a major threat to global public health. Despite substantial advances in early diagnosis and therapeutic strategies, patient outcomes vary widely due to the pronounced molecular and clinical heterogeneity of tumors. Accurate identification of cancer subtypes is therefore essential for elucidating tumor heterogeneity, improving prognostic assessment, and enabling precision medicine. In recent years, multi-omics technologies have provided unprecedented opportunities to characterize cancer at multiple molecular layers, including genomic, epigenomic, transcriptomic, and proteomic levels. However, effectively integrating high-dimensional and heterogeneous multi-omics data remains a major challenge. Moreover, many existing graph convolutional network-based integration methods suffer from over-smoothing and limited utilization of deep feature representations, which restrict their ability to capture complex multi-scale relationships inherent in cancer biology. To address these challenges, we propose MoJKNet, a novel multi-omics integration framework for cancer subtype classification. MoJKNet incorporates a jumping knowledge network (JK-Net) to adaptively aggregate node representations across multiple propagation depths, thereby alleviating over-smoothing and enhancing feature extraction within each omics modality. Subsequently, a multimodal autoencoder combined with similarity network fusion (SNF) is employed to capture complementary information across different omics layers. Finally, a graph attention network (GAT) assigns adaptive feature weights to enable accurate cancer subtype prediction. We evaluated MoJKNet on seven cancer types from The Cancer Genome Atlas (TCGA). Experimental results demonstrate that MoJKNet consistently outperforms state-of-the-art methods, including MOGCAN, MOGONET, and MoGCN, in terms of precision, recall, and F1-score, achieving nearly a 10% performance improvement on the COADREAD dataset. Ablation studies further confirm the critical contribution of the jumping knowledge mechanism to improved representation learning. Overall, MoJKNet provides an effective and generalizable solution for multi-omics data integration and cancer subtype classification, with strong potential for downstream biological interpretation and translational applications.
Indexed as
Identifiers
What OpenQuestion holds
Registered trials
Read under generation 80e0d062 · epoch 390. Bibliography from PubMed, PubMed Central and OpenAlex; grants from NIH RePORTER; trial links from ClinicalTrials.gov; estimates, votes and beliefs from the OpenQuestion graph.